Ted Yednock Sells 16,190 Shares of Annexon, Inc. (NASDAQ:ANNX) Stock

Annexon, Inc. (NASDAQ:ANNX) EVP Ted Yednock sold 16,190 shares of the business’s stock in a transaction that occurred on Monday, September 13th. The stock was sold at an average price of $20.00, for a total value of $323,800.00. Following the sale, the executive vice president now owns 15,000 shares of the company’s stock, valued at $300,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of Annexon stock opened at $22.04 on Friday. Annexon, Inc. has a 52 week low of $15.52 and a 52 week high of $38.01. The business’s fifty day simple moving average is $19.86 and its 200-day simple moving average is $22.72. The firm has a market cap of $844.84 million, a PE ratio of -7.65 and a beta of 1.39.

Annexon (NASDAQ:ANNX) last posted its quarterly earnings data on Sunday, August 15th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.69) by ($0.13). On average, research analysts expect that Annexon, Inc. will post -3 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Morgan Stanley increased its holdings in Annexon by 176.6% during the 2nd quarter. Morgan Stanley now owns 96,654 shares of the company’s stock worth $2,175,000 after purchasing an additional 61,709 shares during the period. Sphera Funds Management LTD. purchased a new stake in Annexon during the 2nd quarter worth about $3,339,000. Invesco Ltd. purchased a new stake in Annexon during the 2nd quarter worth about $265,000. Metropolitan Life Insurance Co NY increased its holdings in Annexon by 108,962.5% during the 2nd quarter. Metropolitan Life Insurance Co NY now owns 8,725 shares of the company’s stock worth $196,000 after purchasing an additional 8,717 shares during the period. Finally, Bank of America Corp DE increased its holdings in Annexon by 15.5% during the 2nd quarter. Bank of America Corp DE now owns 10,768 shares of the company’s stock worth $243,000 after purchasing an additional 1,444 shares during the period.

Separately, Zacks Investment Research lowered Annexon from a “hold” rating to a “sell” rating in a research note on Friday, August 20th.

About Annexon

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration.

Featured Article: Investing strategies using the yield curve

Insider Buying and Selling by Quarter for Annexon (NASDAQ:ANNX)

Receive News & Ratings for Annexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Annexon and related companies with MarketBeat.com's FREE daily email newsletter.